← All organizations

Caladrius Biosciences

For profitWebsite ↗

Also known as: Caladrius Biosciences, Inc. | Chief Medical Officer, Caladrius Biosciences | China Cell Technology Ltd | China Cell Technology Ltd. licensed CBMG to conduct the clinical trial as the sponsor in China | NeoStem Oncology, LLC

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2005

Last known activity

Sep 15, 2021

Timeline

2000s

  1. Jun 1, 2005

    Caladrius Biosciences— Founded

2010s

  1. Jan 19, 2011

    Progenitor Cell Therapy— Acquired

  2. Jan 20, 2011

    PCT Cell Therapy Services— Acquired

  3. Jul 14, 2011

    Amorcyte— Acquired

  4. Apr 15, 2014

    California Stem Cell— Acquired

2020s

  1. Apr 27, 2022

    Cend Therapeutics Inc.— Acquired

Drugs by trial phase (16 distinct, 15 trials)

Indications

Subsidiaries (5 direct, 5 total across the full acquisition tree)

Recent trials (20)

Details

Founded
Irvine, CA, US Jun 1, 2005
Last known activity
Sep 15, 2021

Notes

--- Pre-folding founded info: 2006-06-01 Basking Ridge NJ US https://www.crunchbase.com/organization/caladrius-biosciences#section-overview ---